Innovating the way we see and treat cancer

We are focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need.

Our technology

The unique potential of Radiopharmaceuticals in treating oncological diseases.

Learn more

Our pipeline

The unique potential of being First to Market or Best in Class.

Learn more

Our team

We have a unique commitment to improve patients’ hope in fighting cancer.

Learn more

Information for investors

Stock price, Company governance & updates from our multiple development programs.

Learn more

Latest news

Media Coverage

Bulls N' Bears Interview

November 29, 2021

Read moreRead more

ASX Releases

ASX Investor Presentation 29 Nov 2021

November 29, 2021

Read moreRead more

ASX Releases

Radiopharm Theranostics Lists on the ASX After Raising $50M in IPO

November 25, 2021

Read moreRead more